Dengue 1 virus and dengue hemorrhagic fever, French Polynesia, 2001

Emerging Infectious Diseases

Volumn 15, Issue 8, 2009, Pages 1265-1270

  Hubert, Bruno ^a,c   Halstead, Scott B ^b  

^a Directorate of Health   (French Polynesia)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^c Cellule Inter Régionale d'Épidémiologie ^*  (France)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

AGE DISTRIBUTION; ARTICLE; DENGUE; DENGUE VIRUS; DENGUE VIRUS 1; DISEASE SURVEILLANCE; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIC; FRENCH POLYNESIA; HOSPITALIZATION; INCIDENCE; NONHUMAN; PATHOGENICITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK FACTOR; VIRUS ISOLATION;

ADOLESCENT; AGE FACTORS; CHILD; CHILD, PRESCHOOL; COMMUNICABLE DISEASES, EMERGING; DENGUE HEMORRHAGIC FEVER; DENGUE VIRUS; DISEASE OUTBREAKS; HUMANS; INFANT; INFANT, NEWBORN; POLYNESIA; RISK FACTORS; SEROTYPING; TIME FACTORS; YOUNG ADULT;

EID: 68049101369     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1508.081500     Document Type: Article

References (30)

1. Guzman MG, Kouri GP, Bravo J, Soler M, Vazquez S, Morier L. Dengue hemorrhagic fever in Cuba, 1981: a retrospective seroepidemiologic study. Am J Trop Med Hyg. 1990;42:179-84.
2. Guzman MG, Kouri G, Valdes L, Bravo J, Alvarez M, Vazques S, et al. Epidemiologic studies on Dengue in Santiago de Cuba, 1997. Am J Epidemiol. 2000;152:793-9. DOI: 10.1093/aje/152.9.793
3. Rodriguez-Roche R, Alvarez M, Holmes EC, Bernardo L, Kouri G, Gould EA,. et al. Dengue virus type 3, Cuba, 2000-2002. Emerg Infect Dis. 2005;11:773-4.
4. Chungue E, Deparis X, Murgue B. Dengue in French Polynesia: major features, surveillance, molecular epidemiology and current situation. Pac Health Dialog. 1998;5:154-62.
5. Hubert B. Type 1 dengue fever epidemic in French Polynesia - 2001 [monograph on the Internet] [cited 2009 Feb 20]. Available from http://www.spc.int/phs/PPHSN/Outbreak/reports/Dengue-report2001-FrenchPolynesia. pdf
6. World Health Organization. Dengue haemorrhagic fever. Diagnosis, treatment, prevention and control. Geneva: The Organization; 1997.
7. Chungue E, Boutin JP, Roux J. Significance of IgM titration by an immunoenzyme technique for the serodiagnosis and epidemiological surveillance of dengue in French Polynesia [in French]. Res Virol. 1989;140:229-40. DOI: 10.1016/S0923-2516(89)80100-1
8. Laille M, Roche C. Comparison of dengue-1 virus envelope glycoprotein gene sequences from French Polynesia. Am J Trop Med Hyg. 2004;71:478-84.
9. Halstead SB. Neutralization and antibody-dependent enhancement of dengue viruses. Adv Virus Res. 2003;60:421-67. DOI: 10.1016/ S0065-3527(03)60011-4
10. Halstead SB. Pathogenesis of dengue: challenges to molecular biology. Science. 1988;239:476-81. DOI: 10.1126/science.3277268
11. Vaughn DW. Invited commentary: dengue lessons from Cuba. Am J Epidemiol. 2000;152:800-3. DOI: 10.1093/aje/152.9.800
12. Gubler DJ. Dengue and dengue hemorrhagic fever. Clin Microbiol Rev. 1998;11:480-96.
13. Rico-Hesse R, Harrison LM, Salas RA, Tovar D, Nisalak A, Ramos C, et al. Origins of dengue type 2 viruses associated with increased pathogenicity in the Americas. Virology. 1997;230:244-51. DOI: 10.1006/viro.1997.8504
14. Nimmannitya S, Halstead SB, Cohen SN, Margiotta MR. Dengue and chikungunya virus infection in man in Thailand, 1962-1964. I. Observations on hospitalized patients with hemorrhagic fever. Am J Trop Med Hyg. 1969;18:954-71.
15. Halstead SB, Lan NT, Myint TT, Shwe TN, Nisalak A, Kalyanarooj S, et al. Dengue hemorrhagic fever in infants: research opportunities ignored. Emerg Infect Dis. 2002;8:1474-9.
16. Kliks SC, Nimmanitya S, Nisalak A, Burke DS. Evidence that maternal dengue antibodies are important in the development of dengue hemorrhagic fever in infants. Am J Trop Med Hyg. 1988;38:411-9.
17. Watanaveeradej V, Endy TP, Samakoses R, Kerdpanich A, Simasathien S, Polprasert N, et al. Transplacentally transferred maternal-infant antibodies to dengue virus. Am J Trop Med Hyg. 2003;69:123-8.
18. Chau TN, Quyen NT, Thuy TT, Tuan NM, Hoang DM, Dung NT, et al. Dengue in Vietnamese infants-results of infection-enhancement assays correlate with age-related disease epidemiology, and cellular immune responses correlate with disease severity. J Infect Dis. 2008;198:516-24. DOI: 10.1086/590117
19. Simmons CP, Chau TN, Thuy TT, Tuan NM, Hoang DM, Thien NT, et al. Maternal antibody and viral factors in the pathogenesis of dengue virus in infants. J Infect Dis. 2007;196:416-24. DOI: 10.1086/519170
20. Siegrist CA. Neonatal and early life vaccinology. Vaccine. 2001;19:3331-46. DOI: 10.1016/S0264-410X(01)00028-7
21. Guzman MG, Kouri G, Bravo J, Valdes L, Vazquez S, Halstead SB. Effect of age on outcome of secondary dengue 2 infections. Int J Infect Dis. 2002;6:118-24. DOI: 10.1016/S1201-9712(02)90072-X
22. Gamble J, Bethell D, Day NP, Loc PP, Phu NH, Gartside IB, et al. Age-related changes in microvascular permeability: a significant factor in the susceptibility of children to shock? Clin Sci (Lond). 2000;98:211-6. DOI: 10.1042/CS19990296
23. Bethell DB, Gamble J, Pham PL, Nguyen MD, Tran TH, Ha TH, et al. Noninvasive measurement of microvascular leakage in patients with dengue hemorrhagic fever. Clin Infect Dis. 2001;32:243-53. DOI: 10.1086/318453
24. Imrie A, Zhao Z, Bennett SN, Kitsutani P, Laille M, Effler P. Molecular epidemiology of dengue in the Pacific: introduction of two distinct strains of the dengue type-1 virus into Hawaii. Ann Trop Med Parasitol. 2006;100:327-36. DOI: 10.1179/136485906X105589
25. Caceres C, Yung V, Araya P, Tognarelli J, Villagra E, Vera L, et al. Complete nucleotide sequence analysis of a dengue-1 virus isolated on Easter Island, Chile. Arch Virol. 2008;153:1967-70. DOI: 10.1007/s00705-008-0200-0
26. Perret C, Abarca K, Ovalle J, Ferrer P, Godoy P, Olea A, et al. Dengue-1 virus isolation during first dengue fever outbreak on Easter Island, Chile. Emerg Infect Dis. 2003;9:1465-7.
27. Effler PV, Pang L, Kitsutani P, Vorndam V, Nakata M, Ayers T, et al. Dengue fever, Hawaii, 2001-2002. Emerg Infect Dis. 2005;11:742-9.
28. Sangkawibha N, Rojanasuphot S, Ahandrik S, Viriyapongse S, Jatanasen S, Salitul V, et al. Risk factors in dengue shock syndrome: a prospective epidemiologic study in Rayong, Thailand. I. The 1980 outbreak. Am J Epidemiol. 1984;120:653-69.
29. Vaughn DW, Green S, Kalayanarooj S, Innis BL, Nimmannitya S, Suntayakorn S, et al. Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. J Infect Dis. 2000;181:2-9. DOI: 10.1086/315215
30. Gibbons RV, Kalanarooj S, Jarman R, Nisalak A, Vaughn DW, Endy TP, et al. Analysis of repeat hospital admissions for dengue to estimate the frequency of third or fourth dengue infections resulting in admissions and dengue hemorrhagic fever, and serotype sequences. Am J Trop Med Hyg. 2007;77:910-3.